|
CN111455060A
|
|
Related biomarker for diagnosing and treating oral squamous cell carcinoma and application
|
|
CN111394471A
|
|
L INC00494 application as cervical cancer diagnosis and treatment marker
|
|
CN111440874A
|
|
Biomarker for diagnosing and treating oral squamous cell carcinoma
|
|
CN111440875A
|
|
Biomarker-based diagnosis and use for treating cancer
|
|
CN111394472A
|
|
L INC01598 application in cervical cancer diagnosis and treatment
|
|
CN111560437A
|
|
Biomarkers for predicting oral squamous carcinoma and their use in therapy
|
|
CN111455059A
|
|
Application of reagent for detecting and targeting biomarkers in oral squamous cell carcinoma
|
|
CN111500736A
|
|
Non-coding RNA (ribonucleic acid) as diagnosis and treatment marker of cervical cancer
|
|
CN111575381A
|
|
Novel use of biomarkers
|
|
CN111500737A
|
|
Diagnosis and treatment target-L INC01537 of cervical cancer
|
|
CN111455061A
|
|
Application of lncRNA biomarker in oral squamous cell carcinoma diagnosis and treatment
|
|
CN111518912A
|
|
Application of LINC02178 as diagnosis and treatment marker of cervical cancer
|
|
CN111281872A
|
|
Afatinib-containing pharmaceutical composition and application thereof
|
|
CN111228271A
|
|
Lapatinib-containing pharmaceutical composition and application thereof
|
|
CN111041103A
|
|
Biomarker and application thereof in lung cancer
|
|
CN111088355A
|
|
Molecular marker and kit for gastric cancer diagnosis
|
|
CN110885885A
|
|
Gene marker for diagnosing and treating Alzheimer disease
|
|
CN110951867A
|
|
Biomarkers and their use in alzheimer's disease
|
|
CN110938686A
|
|
Reagent and product for detecting WAS gene and application of WAS gene
|
|
CN110872623A
|
|
Molecular marker gene-BLM as diagnosis and treatment for Parkinson's disease
|
